uniQure plans UK regulatory filing for Huntington's disease gene therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. NVDA
6. ZS
7. AWK
8. DRI
9. ULS
10. QQQ

Go back to uniQure plans UK regulatory filing for Huntington's disease gene therapy
UNIQURE (NASDAQ: QURE) Delayed: 38.23 -0.09 (0.23%)
Previous Close $38.32    52 Week High $22.79 
Open $38.19    52 Week Low $6.63 
Day High $39.12    P/E N/A 
Day Low $37.62    EPS $0.00 
Volume 1,173,714